CombinatoRx

CombinatoRx is pioneering the new field of synergistic combination pharmaceuticals, that is, combining drugs already approved by the FDA to create new applications. The CombinatoRx proprietary drug discovery technology provides a renewable and previously untapped source of novel drug candidates.


Investment

Series B